Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 December 2024

European Medicines Agency’s data protection notice regarding the experts database and the handling of competing interests of scientific committees’ members and experts

Draft qualification opinion for artificial intelligence-based measurement of non-alcoholic steatohepatitis histology in liver biopsies to determine disease activity in NASH/MASH clinical trials

Q&A Clinic on post-authorisation procedure management in IRIS - 11 Dec 2024, Online, from 11 December 2024, 11:00 (CET) to 11 December 2024, 12:00 (CET)

Q&A Clinic on post-authorisation procedure management in IRIS (1), Online, from 11 December 2024, 11:00 (CET) to 11 December 2024, 12:00 (CET)

Ibandronic acid Accord

Human medicines European public assessment report (EPAR): Alli (previously Orlistat GSK), orlistat, Date of authorisation: 22/07/2007, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Esperoct, turoctocog alfa pegol, Date of authorisation: 20/06/2019, Revision: 8, Status: Authorised

Clinical investigation of human normal immunoglobulin for subcutaneous and/or intramuscular administration (SCIg/IMIg) - Scientific guideline

EMA workshop on the challenges in drug development, regulation and clinical practice in hemoglobinopathies, Online, European Medicines Agency, Amsterdam, the Netherlands, from 1 July 2024, 14:00 (CEST) to 1 July 2024, 18:00 (CEST)